Concerns, Beliefs and Attitudes of Pharmacists About Medical Cannabis Use in Poland

TL;DR

This study explores Polish pharmacists' and pharmacy students' attitudes toward medical cannabis, finding openness to its use but highlighting the need for more education.

Contribution

The study provides new insights into pharmacists' and pharmacy students' attitudes toward medical cannabis in Poland, emphasizing the need for targeted education.

Findings

Over 48% of respondents believe cannabis should be used exclusively for medical purposes.

More than 90% consider cannabis effective for treating adults, and nearly 70% see potential for treating children.

Over 66% feel comfortable discussing medical cannabis with patients, but fewer are confident in providing detailed advice.

Abstract

Introduction: The global use of medical cannabis is steadily increasing. In Poland, medical cannabis was legalised in 2017; however, its use remains limited and not widely integrated into clinical practice. This study aimed to explore the attitudes, concerns, and beliefs of pharmacists and pharmacy students regarding the medical use of cannabis. Methods: A study was conducted in 2021 among 422 pharmacists and pharmacy students in Poland, primarily working in community pharmacies. Data were collected using a custom-designed questionnaire addressing beliefs, concerns, and professional experiences related to medical cannabis. Results: Nearly half of the respondents (48.9%) believe that cannabis should be used exclusively for medical purposes, while 47.6% support its use for both medical and recreational purposes following legalisation. A substantial majority (over 90%) consider cannabis effective for treating adults, with nearly 70% acknowledging its potential for treating children. Over 66% of respondents feel comfortable discussing medical cannabis with patients; however, fewer are confident in providing detailed advice about its use. The findings also highlight concerns about the long-term effects and potential legal implications of dispensing medical cannabis. Conclusions: Pharmacists and pharmacy students in Poland demonstrate openness to the medical use of cannabis and recognise its therapeutic potential. However, to enhance their ability to advise patients effectively, targeted educational initiatives are needed. These should focus on the clinical applications, safety, and long-term effects of cannabis, alongside strategies for addressing patient concerns and ensuring responsible usage.

Figures